Servier Laboratories Limited is a Canadian-based, privately held pharmaceutical company established in 1963. Located at Sefton House in Slough, Ontario, the company operates as a limited liability company (Ltd.) with a focus on developing and commercializing innovative therapies for patients worldwide. Servier specializes in the research, development, and manufacturing of pharmaceutical products across various therapeutic areas, including oncology, immunology, and rare diseases. The company’s core business centers around intellectual property and strategic partnerships, aiming to address unmet medical needs. Servier Laboratories is committed to advancing healthcare through targeted therapies and a robust pipeline of novel drug candidates. They maintain a significant international presence, with operations spanning North America, Europe, and Asia. Servier’s size estimate is considered medium-sized, reflecting a dedicated team of scientists, researchers, and business professionals. The company’s key focus is on delivering impactful treatments that improve patient outcomes and quality of life. Servier Laboratories actively seeks to expand its international reach through strategic alliances and collaborations. The company’s SIC codes include: - 46460 (Wholesale of pharmaceutical goods), - 4711 (Pharmaceutical manufacturing), - 4712 (Pharmaceutical research and development), - 4713 (Pharmaceutical marketing), and - 4714 (Pharmaceutical distribution).

Servier Laboratories Limited is a Canadian-based, privately held pharmaceutical company established in 1963. Located at Sefton House in Slough, Ontario, the company operates as a limited liability company (Ltd.) with a focus on developing and commercializing innovative therapies for patients worldwide. Servier specializes in the research, development, and manufacturing of pharmaceutical products across various therapeutic areas, including oncology, immunology, and rare diseases. The company’s core business centers around intellectual property and strategic partnerships, aiming to address unmet medical needs. Servier Laboratories is committed to advancing healthcare through targeted therapies and a robust pipeline of novel drug candidates. They maintain a significant international presence, with operations spanning North America, Europe, and Asia. Servier’s size estimate is considered medium-sized, reflecting a dedicated team of scientists, researchers, and business professionals. The company’s key focus is on delivering impactful treatments that improve patient outcomes and quality of life. Servier Laboratories actively seeks to expand its international reach through strategic alliances and collaborations. The company’s SIC codes include: - 46460 (Wholesale of pharmaceutical goods), - 4711 (Pharmaceutical manufacturing), - 4712 (Pharmaceutical research and development), - 4713 (Pharmaceutical marketing), and - 4714 (Pharmaceutical distribution).